Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between the type of thyroid dysfunction induced by immune checkpoint inhibitors and prognosis in cancer patients
Han-Sang Baek, Chaiho Jeong, Kabsoo Shin, et al.
BMC Endocrine Disorders (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
Mary O’Brien, Luis Paz‐Ares, Sandrine Marréaud, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 10, pp. 1274-1286
Closed Access | Times Cited: 463
Best practices in the management of thyroid dysfunction induced by immune checkpoint inhibitors
Ichiro Yamauchi, Daisuke Yabe
European Thyroid Journal (2025)
Open Access | Times Cited: 3
Implication of the Gut Microbiome and Microbial-Derived Metabolites in Immune-Related Adverse Events: Emergence of Novel Biomarkers for Cancer Immunotherapy
Dávid Dóra, Syeda Mahak Zahra Bokhari, Kenan Aloss, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2769-2769
Open Access | Times Cited: 26
Thyroid disorders induced by immune checkpoint inhibitors
Dimitra Karaviti, Eleni-Rafaela Kani, Eleftheria Karaviti, et al.
Endocrine (2024) Vol. 85, Iss. 1, pp. 67-79
Open Access | Times Cited: 11
Risk factors of immune-related endocrine toxicities in non-small cell lung cancer patients treated with pembrolizumab and its impact on patient outcomes: a multicenter retrospective study
Haoting Zhang, Jing Zheng, C. Ren, et al.
BMC Pulmonary Medicine (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Thyroid-related adverse events induced by immune checkpoint inhibitors
Alexandra Chera, Andreea Lucia Stancu, Octavian Bucur
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 27
Thyroid dysfunction after immune checkpoint inhibitor treatment in a single-center Chinese cohort: a retrospective study
Lingge Wu, Yan Xu, Xiang Wang, et al.
Endocrine (2023) Vol. 81, Iss. 1, pp. 123-133
Open Access | Times Cited: 14
Clinical outcomes of endocrine and other disorders induced by immune checkpoint inhibitors in Japanese patients
Yuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Thyroid Dysfunction After Intensity-Modulated Radiotherapy and PD⁃1 Inhibitor Treatment for Locally Advanced Nasopharyngeal Carcinoma
Kai Shang, Qianyong He, Xinyu Xu, et al.
Therapeutics and Clinical Risk Management (2025) Vol. Volume 21, pp. 15-25
Open Access
Thyroid Dysfunction as a Predictor of PD-1/PD-L1 Inhibitor Efficacy in Advanced Lung Cancer
Yanling Wang, Xiaoping Ma, Jia Ma, et al.
Research Square (Research Square) (2025)
Closed Access
Clinical manifestations and risk factors of immune-related thyroid adverse events in patients treated with PD-1 inhibitors: a case-control study
Pengfei Zhao, Jia Li, Lihong Yu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Thyroid dysfunction as a predictor of PD- 1/PD-L1 inhibitor efficacy in advanced lung cancer
Yanling Wang, Xiaoping Ma, Jia Ma, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review
Nicia I. Profili, Roberto Castelli, Antonio Gidaro, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 5161-5161
Open Access | Times Cited: 10
Immunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for cancer
Kaitlin R. McCarter, Senada Arabelovic, Xiaosong Wang, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 64, pp. 152335-152335
Closed Access | Times Cited: 5
Thyroid dysfunction (TD) induced by PD-1/PD-L1 inhibitors in advanced lung cancer
Yanling Wang, Xiaoxuan Yang, Jia Ma, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27077-e27077
Open Access | Times Cited: 1
Thyroid dysfunction induced by immune checkpoint inhibitors and tumor progression during neoadjuvant therapy of non‑small cell lung cancer: A case report and literature review
Xinyi Li, Xun Wang, Shaodong Wang, et al.
Oncology Letters (2023) Vol. 26, Iss. 5
Open Access | Times Cited: 3
Preconditioning of the immune system modulates the response of papillary thyroid cancer to immune checkpoint inhibitors
Fabiana Pani, Yoshinori Yasuda, Sylvie Rousseau, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 12, pp. e005538-e005538
Open Access | Times Cited: 5
Immune-related thyroid dysfunction as a positive prognostic factor for patients with lung cancer in China: a real-world retrospective study
Ge Guo, Zihan Jing, Wenbin Dou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Thyroid-related Adverse Events Caused by Immune Checkpoint Inhibitors Associated with Therapeutic Outcomes in Cancer Patients: a systematic review and meta-analysis
Yuhao Wei, Yun Hong, Xueyan Zhou, et al.
Research Square (Research Square) (2023)
Open Access
Atezolizumab/pembrolizumab

Reactions Weekly (2022) Vol. 1907, Iss. 1, pp. 85-85
Closed Access
Thyroid dysfunction after immune checkpoint inhibitor treatment in a single-center Chinese cohort: a retrospective study
Lingge Wu, Yan Xu, Xiang Wang, et al.
Research Square (Research Square) (2022)
Open Access
Case 5: A 41-Year-Old Woman With Palpitation
Ji Won Yang, Kabsoo Shin, Jeongmin Lee, et al.
Journal of Korean Medical Science (2022) Vol. 37, Iss. 47
Open Access
Page 1

Scroll to top